Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency

David R Anderson1, Marvin J Meyers, Ravi G Kurumbail

  • 1Pfizer Global Research and Development, St Louis Laboratories, Chesterfield, MO 63017, USA. david.r.anderson@pfizer.com

Related Concept Videos